JOSEPH J JR GRANO

CIK 1304755 · CEO and Chairman · last filed 2025-07-03

JOSEPH J JR GRANO is a CEO and Chairman who has filed 35 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for VIRT, was dated Jul 3, 2025. Across all open-market trades the lifetime net is −$130.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.24M

Companies

6

Total Filings

35

Lifetime Open-Market Net

-$130.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VIRT Director 38,822 $57.62 $2.24M $0 5 2025-07-03
Aevi Genomic Medicine, LLC (GNMX) Delisted Director 102,683 $28.9K 5 2018-11-13
root9B Holdings, Inc. (RTNB) Delisted CEO and Chairman $0 1 2017-01-27
Aevi Genomic Medicine, LLC (MDGN) Delisted Director 74,164 -$15.8K 2 2016-12-12
Aevi Genomic Medicine, LLC (MDGN.WS) Delisted Director 71,164 $300.0K 5 2015-10-08
AMERITYRE CORP (AMTY) Delisted 76,367 -$443.4K 5 2008-01-17

Recent Filings

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-07-03 VIRT Mixed +6,681 $0 EDGAR
2024-07-03 VIRT Mixed +8,760 $0 EDGAR
2023-07-03 VIRT Mixed +6,365 $0 EDGAR
2022-07-01 VIRT Mixed +4,880 $0 EDGAR
2021-07-02 VIRT Mixed +5,811 $0 EDGAR
2020-02-05 Disp (D) −174,847 $0
2018-11-13 Aevi Genomic Medicine, LLC (GNMX) Delisted Buy (P) +68,000 $78.9K EDGAR
2018-07-18 Aevi Genomic Medicine, LLC (GNMX) Delisted Grant (A) $0 EDGAR
2018-06-18 Aevi Genomic Medicine, LLC (GNMX) Delisted Grant (A) $0 EDGAR
2017-10-18 Aevi Genomic Medicine, LLC (GNMX) Delisted Buy (P) −39,683 -$50.0K EDGAR
Showing 110 of 35
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.